nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCG2—Dactinomycin—muscle cancer	0.121	0.144	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—muscle cancer	0.0974	0.116	CbGbCtD
Telmisartan—ABCC2—Vincristine—muscle cancer	0.0823	0.0981	CbGbCtD
Telmisartan—ABCC2—Etoposide—muscle cancer	0.0755	0.0899	CbGbCtD
Telmisartan—ABCG2—Vincristine—muscle cancer	0.0744	0.0887	CbGbCtD
Telmisartan—ABCG2—Etoposide—muscle cancer	0.0682	0.0812	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—muscle cancer	0.0515	0.0613	CbGbCtD
Telmisartan—ABCC2—Methotrexate—muscle cancer	0.0499	0.0594	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—muscle cancer	0.0465	0.0554	CbGbCtD
Telmisartan—ABCG2—Methotrexate—muscle cancer	0.0451	0.0537	CbGbCtD
Telmisartan—ABCB1—Dactinomycin—muscle cancer	0.0436	0.0519	CbGbCtD
Telmisartan—ABCB1—Vincristine—muscle cancer	0.0268	0.032	CbGbCtD
Telmisartan—ABCB1—Etoposide—muscle cancer	0.0246	0.0293	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—muscle cancer	0.0168	0.02	CbGbCtD
Telmisartan—ABCB1—Methotrexate—muscle cancer	0.0163	0.0194	CbGbCtD
Telmisartan—PPARG—hindlimb—muscle cancer	0.00547	0.156	CbGeAlD
Telmisartan—PPARG—appendage—muscle cancer	0.00469	0.134	CbGeAlD
Telmisartan—PPARG—Teniposide—Etoposide—muscle cancer	0.00434	1	CbGdCrCtD
Telmisartan—SLCO1B3—vagina—muscle cancer	0.00171	0.0489	CbGeAlD
Telmisartan—PPARG—embryo—muscle cancer	0.00156	0.0445	CbGeAlD
Telmisartan—AGTR1—smooth muscle tissue—muscle cancer	0.00149	0.0426	CbGeAlD
Telmisartan—AGTR1—renal system—muscle cancer	0.00143	0.041	CbGeAlD
Telmisartan—AGTR1—cardiac atrium—muscle cancer	0.00128	0.0367	CbGeAlD
Telmisartan—PPARG—smooth muscle tissue—muscle cancer	0.00123	0.035	CbGeAlD
Telmisartan—PPARG—renal system—muscle cancer	0.00118	0.0337	CbGeAlD
Telmisartan—AGTR1—tendon—muscle cancer	0.00112	0.032	CbGeAlD
Telmisartan—AGTR1—vagina—muscle cancer	0.00104	0.0297	CbGeAlD
Telmisartan—ABCC2—renal system—muscle cancer	0.00104	0.0296	CbGeAlD
Telmisartan—AGTR1—head—muscle cancer	0.00096	0.0274	CbGeAlD
Telmisartan—AGTR1—testis—muscle cancer	0.000927	0.0265	CbGeAlD
Telmisartan—PPARG—tendon—muscle cancer	0.000921	0.0263	CbGeAlD
Telmisartan—PPARG—bone marrow—muscle cancer	0.000892	0.0255	CbGeAlD
Telmisartan—PPARG—vagina—muscle cancer	0.000855	0.0244	CbGeAlD
Telmisartan—ABCC2—tendon—muscle cancer	0.000809	0.0231	CbGeAlD
Telmisartan—PPARG—head—muscle cancer	0.000789	0.0226	CbGeAlD
Telmisartan—PPARG—testis—muscle cancer	0.000763	0.0218	CbGeAlD
Telmisartan—ABCC2—testis—muscle cancer	0.00067	0.0191	CbGeAlD
Telmisartan—CYP2C19—vagina—muscle cancer	0.000645	0.0184	CbGeAlD
Telmisartan—ABCG2—bone marrow—muscle cancer	0.000572	0.0163	CbGeAlD
Telmisartan—ABCG2—vagina—muscle cancer	0.000548	0.0156	CbGeAlD
Telmisartan—ABCB1—embryo—muscle cancer	0.000493	0.0141	CbGeAlD
Telmisartan—ABCG2—testis—muscle cancer	0.000489	0.014	CbGeAlD
Telmisartan—ABCB1—renal system—muscle cancer	0.000373	0.0107	CbGeAlD
Telmisartan—Breast disorder—Methotrexate—muscle cancer	0.000304	0.00251	CcSEcCtD
Telmisartan—Vertigo—Etoposide—muscle cancer	0.000303	0.00251	CcSEcCtD
Telmisartan—Purpura—Doxorubicin—muscle cancer	0.000302	0.00249	CcSEcCtD
Telmisartan—Abdominal pain—Dactinomycin—muscle cancer	0.000301	0.00249	CcSEcCtD
Telmisartan—Body temperature increased—Dactinomycin—muscle cancer	0.000301	0.00249	CcSEcCtD
Telmisartan—Hypoglycaemia—Doxorubicin—muscle cancer	0.000298	0.00246	CcSEcCtD
Telmisartan—Loss of consciousness—Etoposide—muscle cancer	0.000297	0.00245	CcSEcCtD
Telmisartan—Decreased appetite—Vincristine—muscle cancer	0.000296	0.00245	CcSEcCtD
Telmisartan—Cough—Etoposide—muscle cancer	0.000295	0.00244	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Vincristine—muscle cancer	0.000294	0.00243	CcSEcCtD
Telmisartan—Fatigue—Vincristine—muscle cancer	0.000293	0.00243	CcSEcCtD
Telmisartan—Hypertension—Etoposide—muscle cancer	0.000292	0.00241	CcSEcCtD
Telmisartan—Pain—Vincristine—muscle cancer	0.000291	0.00241	CcSEcCtD
Telmisartan—Constipation—Vincristine—muscle cancer	0.000291	0.00241	CcSEcCtD
Telmisartan—Osteoarthritis—Doxorubicin—muscle cancer	0.000291	0.0024	CcSEcCtD
Telmisartan—Pain in extremity—Doxorubicin—muscle cancer	0.000291	0.0024	CcSEcCtD
Telmisartan—Asthma—Methotrexate—muscle cancer	0.00029	0.0024	CcSEcCtD
Telmisartan—Chest pain—Etoposide—muscle cancer	0.000288	0.00238	CcSEcCtD
Telmisartan—Eosinophilia—Methotrexate—muscle cancer	0.000287	0.00238	CcSEcCtD
Telmisartan—Migraine—Doxorubicin—muscle cancer	0.000286	0.00237	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000286	0.00236	CcSEcCtD
Telmisartan—Discomfort—Etoposide—muscle cancer	0.000284	0.00235	CcSEcCtD
Telmisartan—ABCB1—bone marrow—muscle cancer	0.000282	0.00806	CbGeAlD
Telmisartan—Face oedema—Doxorubicin—muscle cancer	0.000281	0.00232	CcSEcCtD
Telmisartan—Hypersensitivity—Dactinomycin—muscle cancer	0.000281	0.00232	CcSEcCtD
Telmisartan—Abdominal discomfort—Methotrexate—muscle cancer	0.000278	0.0023	CcSEcCtD
Telmisartan—Gastrointestinal pain—Vincristine—muscle cancer	0.000278	0.0023	CcSEcCtD
Telmisartan—Anaphylactic shock—Etoposide—muscle cancer	0.000276	0.00228	CcSEcCtD
Telmisartan—Infection—Etoposide—muscle cancer	0.000274	0.00226	CcSEcCtD
Telmisartan—Asthenia—Dactinomycin—muscle cancer	0.000273	0.00226	CcSEcCtD
Telmisartan—Blood creatinine increased—Doxorubicin—muscle cancer	0.000273	0.00225	CcSEcCtD
Telmisartan—Dysuria—Methotrexate—muscle cancer	0.000272	0.00224	CcSEcCtD
Telmisartan—ABCB1—vagina—muscle cancer	0.00027	0.00772	CbGeAlD
Telmisartan—Thrombocytopenia—Etoposide—muscle cancer	0.00027	0.00223	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00027	0.00223	CcSEcCtD
Telmisartan—Tachycardia—Etoposide—muscle cancer	0.000269	0.00222	CcSEcCtD
Telmisartan—Body temperature increased—Vincristine—muscle cancer	0.000269	0.00222	CcSEcCtD
Telmisartan—Abdominal pain—Vincristine—muscle cancer	0.000269	0.00222	CcSEcCtD
Telmisartan—Skin disorder—Etoposide—muscle cancer	0.000268	0.00221	CcSEcCtD
Telmisartan—Erectile dysfunction—Methotrexate—muscle cancer	0.000267	0.00221	CcSEcCtD
Telmisartan—Dry skin—Doxorubicin—muscle cancer	0.000267	0.0022	CcSEcCtD
Telmisartan—Hyperhidrosis—Etoposide—muscle cancer	0.000267	0.0022	CcSEcCtD
Telmisartan—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000266	0.0022	CcSEcCtD
Telmisartan—Hypokalaemia—Doxorubicin—muscle cancer	0.000265	0.00219	CcSEcCtD
Telmisartan—Breast disorder—Doxorubicin—muscle cancer	0.000263	0.00217	CcSEcCtD
Telmisartan—Anorexia—Etoposide—muscle cancer	0.000263	0.00217	CcSEcCtD
Telmisartan—Diarrhoea—Dactinomycin—muscle cancer	0.000261	0.00215	CcSEcCtD
Telmisartan—Pneumonia—Methotrexate—muscle cancer	0.00026	0.00215	CcSEcCtD
Telmisartan—Infestation—Methotrexate—muscle cancer	0.000259	0.00214	CcSEcCtD
Telmisartan—Infestation NOS—Methotrexate—muscle cancer	0.000259	0.00214	CcSEcCtD
Telmisartan—Depression—Methotrexate—muscle cancer	0.000258	0.00213	CcSEcCtD
Telmisartan—Hypotension—Etoposide—muscle cancer	0.000258	0.00213	CcSEcCtD
Telmisartan—Gastritis—Doxorubicin—muscle cancer	0.000257	0.00213	CcSEcCtD
Telmisartan—Muscular weakness—Doxorubicin—muscle cancer	0.000257	0.00212	CcSEcCtD
Telmisartan—Renal failure—Methotrexate—muscle cancer	0.000255	0.0021	CcSEcCtD
Telmisartan—Abdominal distension—Doxorubicin—muscle cancer	0.000253	0.00209	CcSEcCtD
Telmisartan—Conjunctivitis—Methotrexate—muscle cancer	0.000252	0.00208	CcSEcCtD
Telmisartan—Asthma—Doxorubicin—muscle cancer	0.000251	0.00208	CcSEcCtD
Telmisartan—Hypersensitivity—Vincristine—muscle cancer	0.000251	0.00207	CcSEcCtD
Telmisartan—ABCB1—head—muscle cancer	0.00025	0.00713	CbGeAlD
Telmisartan—Eosinophilia—Doxorubicin—muscle cancer	0.000249	0.00206	CcSEcCtD
Telmisartan—Paraesthesia—Etoposide—muscle cancer	0.000248	0.00205	CcSEcCtD
Telmisartan—Haematuria—Methotrexate—muscle cancer	0.000247	0.00204	CcSEcCtD
Telmisartan—Dyspnoea—Etoposide—muscle cancer	0.000246	0.00203	CcSEcCtD
Telmisartan—Somnolence—Etoposide—muscle cancer	0.000245	0.00203	CcSEcCtD
Telmisartan—Angina pectoris—Doxorubicin—muscle cancer	0.000245	0.00202	CcSEcCtD
Telmisartan—Hepatobiliary disease—Methotrexate—muscle cancer	0.000245	0.00202	CcSEcCtD
Telmisartan—Epistaxis—Methotrexate—muscle cancer	0.000244	0.00202	CcSEcCtD
Telmisartan—Asthenia—Vincristine—muscle cancer	0.000244	0.00202	CcSEcCtD
Telmisartan—Vomiting—Dactinomycin—muscle cancer	0.000242	0.002	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—muscle cancer	0.000242	0.002	CcSEcCtD
Telmisartan—ABCB1—testis—muscle cancer	0.000241	0.00689	CbGeAlD
Telmisartan—Rash—Dactinomycin—muscle cancer	0.00024	0.00199	CcSEcCtD
Telmisartan—Decreased appetite—Etoposide—muscle cancer	0.00024	0.00198	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Etoposide—muscle cancer	0.000238	0.00197	CcSEcCtD
Telmisartan—Fatigue—Etoposide—muscle cancer	0.000238	0.00196	CcSEcCtD
Telmisartan—Pain—Etoposide—muscle cancer	0.000236	0.00195	CcSEcCtD
Telmisartan—Constipation—Etoposide—muscle cancer	0.000236	0.00195	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—muscle cancer	0.000235	0.00194	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000234	0.00193	CcSEcCtD
Telmisartan—Diarrhoea—Vincristine—muscle cancer	0.000233	0.00192	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—muscle cancer	0.000232	0.00192	CcSEcCtD
Telmisartan—Pharyngitis—Methotrexate—muscle cancer	0.000231	0.00191	CcSEcCtD
Telmisartan—Urinary tract disorder—Methotrexate—muscle cancer	0.00023	0.0019	CcSEcCtD
Telmisartan—Urethral disorder—Methotrexate—muscle cancer	0.000228	0.00188	CcSEcCtD
Telmisartan—Feeling abnormal—Etoposide—muscle cancer	0.000227	0.00188	CcSEcCtD
Telmisartan—Nausea—Dactinomycin—muscle cancer	0.000226	0.00187	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—muscle cancer	0.000225	0.00186	CcSEcCtD
Telmisartan—Gastrointestinal pain—Etoposide—muscle cancer	0.000225	0.00186	CcSEcCtD
Telmisartan—Dizziness—Vincristine—muscle cancer	0.000225	0.00186	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—muscle cancer	0.000224	0.00185	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—muscle cancer	0.000224	0.00185	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—muscle cancer	0.000224	0.00185	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—muscle cancer	0.00022	0.00182	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00022	0.00182	CcSEcCtD
Telmisartan—Urticaria—Etoposide—muscle cancer	0.000219	0.00181	CcSEcCtD
Telmisartan—Body temperature increased—Etoposide—muscle cancer	0.000218	0.0018	CcSEcCtD
Telmisartan—Abdominal pain—Etoposide—muscle cancer	0.000218	0.0018	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—muscle cancer	0.000218	0.0018	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—muscle cancer	0.000218	0.0018	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—muscle cancer	0.000217	0.0018	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—muscle cancer	0.000217	0.00179	CcSEcCtD
Telmisartan—Vomiting—Vincristine—muscle cancer	0.000216	0.00179	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—muscle cancer	0.000216	0.00178	CcSEcCtD
Telmisartan—Rash—Vincristine—muscle cancer	0.000215	0.00177	CcSEcCtD
Telmisartan—Dermatitis—Vincristine—muscle cancer	0.000214	0.00177	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—muscle cancer	0.000214	0.00177	CcSEcCtD
Telmisartan—Headache—Vincristine—muscle cancer	0.000213	0.00176	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000212	0.00175	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—muscle cancer	0.000211	0.00175	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—muscle cancer	0.000211	0.00174	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—muscle cancer	0.00021	0.00174	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—muscle cancer	0.00021	0.00174	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—muscle cancer	0.000209	0.00173	CcSEcCtD
Telmisartan—Chills—Methotrexate—muscle cancer	0.000209	0.00172	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—muscle cancer	0.000205	0.00169	CcSEcCtD
Telmisartan—Mental disorder—Methotrexate—muscle cancer	0.000204	0.00168	CcSEcCtD
Telmisartan—Hypersensitivity—Etoposide—muscle cancer	0.000203	0.00168	CcSEcCtD
Telmisartan—Erythema—Methotrexate—muscle cancer	0.000202	0.00167	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—muscle cancer	0.000202	0.00167	CcSEcCtD
Telmisartan—Nausea—Vincristine—muscle cancer	0.000202	0.00167	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—muscle cancer	0.000202	0.00167	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—muscle cancer	0.0002	0.00166	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—muscle cancer	0.0002	0.00165	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—muscle cancer	0.000199	0.00164	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—muscle cancer	0.000198	0.00164	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—muscle cancer	0.000198	0.00164	CcSEcCtD
Telmisartan—Asthenia—Etoposide—muscle cancer	0.000198	0.00163	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—muscle cancer	0.000198	0.00163	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—muscle cancer	0.000197	0.00163	CcSEcCtD
Telmisartan—Back pain—Methotrexate—muscle cancer	0.000196	0.00162	CcSEcCtD
Telmisartan—Pruritus—Etoposide—muscle cancer	0.000195	0.00161	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—muscle cancer	0.000194	0.0016	CcSEcCtD
Telmisartan—Diarrhoea—Etoposide—muscle cancer	0.000189	0.00156	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—muscle cancer	0.000188	0.00155	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—muscle cancer	0.000188	0.00155	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—muscle cancer	0.000188	0.00155	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—muscle cancer	0.000187	0.00155	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—muscle cancer	0.000187	0.00154	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—muscle cancer	0.000187	0.00154	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—muscle cancer	0.000183	0.00151	CcSEcCtD
Telmisartan—Malaise—Methotrexate—muscle cancer	0.000182	0.00151	CcSEcCtD
Telmisartan—Dizziness—Etoposide—muscle cancer	0.000182	0.00151	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—muscle cancer	0.000182	0.0015	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—muscle cancer	0.000182	0.0015	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—muscle cancer	0.000181	0.0015	CcSEcCtD
Telmisartan—Chills—Doxorubicin—muscle cancer	0.000181	0.00149	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—muscle cancer	0.00018	0.00149	CcSEcCtD
Telmisartan—Cough—Methotrexate—muscle cancer	0.000177	0.00146	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—muscle cancer	0.000176	0.00146	CcSEcCtD
Telmisartan—Vomiting—Etoposide—muscle cancer	0.000175	0.00145	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—muscle cancer	0.000175	0.00145	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—muscle cancer	0.000175	0.00145	CcSEcCtD
Telmisartan—Rash—Etoposide—muscle cancer	0.000174	0.00144	CcSEcCtD
Telmisartan—Dermatitis—Etoposide—muscle cancer	0.000174	0.00144	CcSEcCtD
Telmisartan—Headache—Etoposide—muscle cancer	0.000173	0.00143	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—muscle cancer	0.000173	0.00143	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—muscle cancer	0.000172	0.00142	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—muscle cancer	0.000172	0.00142	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—muscle cancer	0.000172	0.00142	CcSEcCtD
Telmisartan—Tension—Doxorubicin—muscle cancer	0.000172	0.00142	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—muscle cancer	0.000172	0.00142	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000171	0.00141	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—muscle cancer	0.00017	0.00141	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—muscle cancer	0.00017	0.00141	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—muscle cancer	0.000169	0.0014	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—muscle cancer	0.000168	0.00139	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—muscle cancer	0.000165	0.00136	CcSEcCtD
Telmisartan—Infection—Methotrexate—muscle cancer	0.000164	0.00136	CcSEcCtD
Telmisartan—Nausea—Etoposide—muscle cancer	0.000164	0.00135	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—muscle cancer	0.000163	0.00134	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—muscle cancer	0.000162	0.00134	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—muscle cancer	0.000162	0.00134	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—muscle cancer	0.000162	0.00134	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—muscle cancer	0.00016	0.00133	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—muscle cancer	0.00016	0.00132	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—muscle cancer	0.000158	0.00131	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—muscle cancer	0.000157	0.0013	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—muscle cancer	0.000157	0.0013	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—muscle cancer	0.000157	0.0013	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—muscle cancer	0.000155	0.00128	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—muscle cancer	0.000154	0.00128	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—muscle cancer	0.000154	0.00127	CcSEcCtD
Telmisartan—Cough—Doxorubicin—muscle cancer	0.000153	0.00126	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—muscle cancer	0.000151	0.00125	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00015	0.00124	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—muscle cancer	0.000149	0.00123	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—muscle cancer	0.000149	0.00123	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—muscle cancer	0.000149	0.00123	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—muscle cancer	0.000149	0.00123	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—muscle cancer	0.000149	0.00123	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—muscle cancer	0.000148	0.00123	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000148	0.00122	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—muscle cancer	0.000147	0.00122	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—muscle cancer	0.000147	0.00122	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—muscle cancer	0.000147	0.00121	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—muscle cancer	0.000146	0.00121	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—muscle cancer	0.000145	0.0012	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—muscle cancer	0.000144	0.00119	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—muscle cancer	0.000143	0.00118	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—muscle cancer	0.000143	0.00118	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000143	0.00118	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—muscle cancer	0.000142	0.00118	CcSEcCtD
Telmisartan—Infection—Doxorubicin—muscle cancer	0.000142	0.00117	CcSEcCtD
Telmisartan—Pain—Methotrexate—muscle cancer	0.000141	0.00117	CcSEcCtD
Telmisartan—Shock—Doxorubicin—muscle cancer	0.000141	0.00116	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—muscle cancer	0.00014	0.00116	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—muscle cancer	0.00014	0.00116	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—muscle cancer	0.00014	0.00115	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—muscle cancer	0.000139	0.00115	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—muscle cancer	0.000138	0.00114	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—muscle cancer	0.000136	0.00113	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—muscle cancer	0.000136	0.00112	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—muscle cancer	0.000135	0.00112	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—muscle cancer	0.000134	0.0011	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—muscle cancer	0.000131	0.00108	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—muscle cancer	0.000131	0.00108	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—muscle cancer	0.000131	0.00108	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00013	0.00108	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—muscle cancer	0.000129	0.00107	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—muscle cancer	0.000128	0.00106	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—muscle cancer	0.000127	0.00105	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—muscle cancer	0.000127	0.00105	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—muscle cancer	0.000126	0.00104	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—muscle cancer	0.000124	0.00103	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000123	0.00102	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—muscle cancer	0.000123	0.00102	CcSEcCtD
Telmisartan—Pain—Doxorubicin—muscle cancer	0.000122	0.00101	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—muscle cancer	0.000122	0.00101	CcSEcCtD
Telmisartan—Hypersensitivity—Methotrexate—muscle cancer	0.000122	0.00101	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—muscle cancer	0.000118	0.000979	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—muscle cancer	0.000118	0.000974	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000117	0.000966	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—muscle cancer	0.000117	0.000966	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—muscle cancer	0.000114	0.000939	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—muscle cancer	0.000113	0.000934	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—muscle cancer	0.000113	0.000934	CcSEcCtD
Telmisartan—Diarrhoea—Methotrexate—muscle cancer	0.000113	0.000934	CcSEcCtD
Telmisartan—Dizziness—Methotrexate—muscle cancer	0.000109	0.000903	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—muscle cancer	0.000105	0.000871	CcSEcCtD
Telmisartan—Vomiting—Methotrexate—muscle cancer	0.000105	0.000868	CcSEcCtD
Telmisartan—Rash—Methotrexate—muscle cancer	0.000104	0.000861	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—muscle cancer	0.000104	0.00086	CcSEcCtD
Telmisartan—Headache—Methotrexate—muscle cancer	0.000103	0.000855	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—muscle cancer	0.000103	0.000848	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—muscle cancer	0.000101	0.000836	CcSEcCtD
Telmisartan—Nausea—Methotrexate—muscle cancer	9.81e-05	0.000811	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—muscle cancer	9.78e-05	0.000809	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—muscle cancer	9.46e-05	0.000782	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—muscle cancer	9.09e-05	0.000751	CcSEcCtD
Telmisartan—Rash—Doxorubicin—muscle cancer	9.02e-05	0.000745	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—muscle cancer	9.01e-05	0.000745	CcSEcCtD
Telmisartan—Headache—Doxorubicin—muscle cancer	8.96e-05	0.00074	CcSEcCtD
Telmisartan—Nausea—Doxorubicin—muscle cancer	8.49e-05	0.000702	CcSEcCtD
